Lv1
98 积分 2024-01-19 加入
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
3个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
6个月前
已完结
Osimertinib in Untreated EGFR -Mutated Advanced Non–Small-Cell Lung Cancer
7个月前
已完结
Well-differentiated fetal adenocarcinoma presenting with cutaneous metastases
8个月前
已完结
[Experience with High-grade Fetal Lung Adenocarcinoma;Report of a Case]
8个月前
已关闭
Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma
10个月前
已完结
The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer
10个月前
已完结
[Introduction to the 9
10个月前
已完结
[The ninth edition of TNM staging for lung cancer: precise staging for precise diagnosis and treatment]
10个月前
已完结
Tumour burden and efficacy of immune-checkpoint inhibitors
10个月前
已完结
皖公网安备34019202002308
